Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global infantile spasms therapeutics market is growing at a slow pace. This is due to the increased availability of generic drugs and less approved therapies in the market and the less awareness of the disease and the available treatment options, especially in the low- and middle-income countries.The classification of Infantile Spasms Therapeutics includes Oral, Injection. The proportion of Injection in 2016 is about 45%, and the proportion of Oral in 2016 is about 55%.Based on application, the nitinol medical devices market is segmented into Hospital, Clinic and others. Clinic segment accounted for larger market share in terms of sales in 2016, Clinic segmented accounted for more than 45% of the market share in 2016.United States is the largest consumption place, with a consumption market share nearly 83% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 12.6% in 2016.The US market is dominated by two approved products H.P. Acthar Gel (adrenocorticotropin hormone) and Sabril (vigabatrin). Sabril was the first drug to be approved by the Food and Drug Administration (FDA) in 2009 and H.P. Acthar Gel (adrenocorticotropin hormone) was approved for infantile spasms in 2010. Both have Orphan Drug Exclusivity (ODE) in the US.In the future, the Infantile Spasms Therapeutics will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the industry is more dispersion.
This report elaborates on the current development of the Infantile Spasms Therapeutics industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.
Competitive Landscape:
Orphelia Pharma
Retrophin
Anavex Life Sciences
Valerion Therapeutics
H Lundbeck
Catalyst Pharmaceuticals
Insys Therapeutics
Mallinckrodt
GW Pharmaceuticals
Region:
-
China
-
North America
-
Europe
-
APAC
-
Latin America, Middle East and Africa
Type:
Oral
Injection
Application:
Hospital
Clinic
Table of Content
Chapter 1 Industry Overview & Development Status in Global and China Market
-
1.1 Infantile Spasms Therapeutics Industry Overview
-
1.1.1 Infantile Spasms Therapeutics Market Scope and Market Segments
-
1.1.2 Infantile Spasms Therapeutics Industry Characteristics
-
1.1.3 Global and China Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
1.1.4 Global and China Infantile Spasms Therapeutics Production Value and Growth Rate (2017-2028)
-
1.2 Global Infantile Spasms Therapeutics Market Size and Growth Rate by Type (2017-2028)
-
1.2.1 Oral
-
1.2.2 Injection
-
1.3 Global Infantile Spasms Therapeutics Market Size and Growth Rate by Application (2017-2028)
-
1.3.1 Hospital
-
1.3.2 Clinic
-
1.4 Market Analysis by Region
-
1.4.1 North America Infantile Spasms Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.2 Europe Infantile Spasms Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.3 APAC Infantile Spasms Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.4.4 Latin America, Middle East and Africa Infantile Spasms Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
1.5 Global Infantile Spasms Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.5.1 Global Infantile Spasms Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
1.6 China Infantile Spasms Therapeutics Sales Volume, Price, Sales Value (2017-2028)
-
1.6.1 China Infantile Spasms Therapeutics Sales Volume, Price, Sales Value (2017-2028)
Chapter 2 Global Infantile Spasms Therapeutics Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Challenges and Restraints
-
2.1.2 Opportunities and Potentialities
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape
-
2.2.1 Market Concentration Rate Analysis
-
2.2.2 Infantile Spasms Therapeutics Industry Porter's Five Forces Model Analysis
-
2.2.3 Infantile Spasms Therapeutics Industry PEST Analysis
-
2.3 Infantile Spasms Therapeutics Industry Chain Analysis
-
2.3.1 Raw Material Supplies
-
2.3.2 Infantile Spasms Therapeutics Downstream Market Analysis
-
2.3.3 Upstream and Downstream Impacts on Infantile Spasms Therapeutics Industry
Chapter 3 Global and China Infantile Spasms Therapeutics Market, by Manufacturer
-
3.1 Global and China Infantile Spasms Therapeutics Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)
-
3.1.1 Global and China Infantile Spasms Therapeutics Sales Volume, by Manufacturer (2021&2022)
-
3.1.2 Global and China Infantile Spasms Therapeutics Sales Value, by Manufacturer (2021&2022)
-
3.1.3 Global and China Infantile Spasms Therapeutics Market Share, by Manufacturer (2021&2022)
-
3.2 SWOT Analysis on Global and China Infantile Spasms Therapeutics Market Top 3 Players
Chapter 4 Global and China Infantile Spasms Therapeutics Market, by Type (2017-2028)
-
4.1 Infantile Spasms Therapeutics Market Trend, by Type
-
4.2 Global Infantile Spasms Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.2.1 Global Infantile Spasms Therapeutics Sales Volume and Market Share, by Type (2017-2028)
-
4.2.2 Global Infantile Spasms Therapeutics Sales Value and Market Share, by Type (2017-2028)
-
4.2.3 Global Infantile Spasms Therapeutics Price Trend, by Type (2017-2028)
-
4.3 China Infantile Spasms Therapeutics Sales Volume, Sales Value, Market Share and Price Trend, by Type
-
4.3.1 China Infantile Spasms Therapeutics Sales Volume and Market Share, by Type (2017-2028)
-
4.3.2 China Infantile Spasms Therapeutics Sales Value and Market Share, by Type (2017-2028)
-
4.3.3 China Infantile Spasms Therapeutics Price Trend, by Type (2017-2028)
Chapter 5 Global and China Infantile Spasms Therapeutics Market, by Application (2017-2028)
-
5.1 Downstream Market Overview
-
5.2 Global Infantile Spasms Therapeutics Sales Volume, Sales Value and Market Share, by Application
-
5.2.1 Global Infantile Spasms Therapeutics Sales Volume and Market Share, by Application (2017-2028)
-
5.2.2 Global Infantile Spasms Therapeutics Sales Value and Market Share, by Application (2017-2028)
-
5.3 China Infantile Spasms Therapeutics Sales Volume, Sales Value and Market Share, by Application
-
5.3.1 China Infantile Spasms Therapeutics Sales Volume and Market Share, by Application (2017-2028)
-
5.3.2 China Infantile Spasms Therapeutics Sales Value and Market Share, by Application (2017-2028)
Chapter 6 Global Infantile Spasms Therapeutics Production, Import, Consumption and Export, by Region (2017-2022)
-
6.1 China Infantile Spasms Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.2 North America Infantile Spasms Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.3 Europe Infantile Spasms Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.4 APAC Infantile Spasms Therapeutics Production, Import, Consumption and Export (2017-2022)
-
6.5 Latin America, Middle East and Africa Infantile Spasms Therapeutics Production, Import, Consumption and Export (2017-2022)
Chapter 7 North America Infantile Spasms Therapeutics Market Analysis
-
7.1 North America Infantile Spasms Therapeutics Market, by Type
-
7.2 North America Infantile Spasms Therapeutics Market, by Application
-
7.3 North America Infantile Spasms Therapeutics Market Analysis and Forecast, by Country
-
7.3.1 United States Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.2 Canada Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
7.3.3 Mexico Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 8 Europe Infantile Spasms Therapeutics Market Analysis
-
8.1 Europe Infantile Spasms Therapeutics Market, by Type
-
8.2 Europe Infantile Spasms Therapeutics Market, by Application
-
8.3 Europe Infantile Spasms Therapeutics Market Analysis and Forecast, by Country
-
8.3.1 Germany Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.2 UK Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.3 France Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.4 Italy Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.5 Nordic Countries Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.6 Spain Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.7 Belgium Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.8 Poland Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.9 Russia Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
8.3.10 Turkey Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 9 APAC Infantile Spasms Therapeutics Market Analysis
-
9.1 APAC Infantile Spasms Therapeutics Market, by Type
-
9.2 APAC Infantile Spasms Therapeutics Market, by Application
-
9.3 APAC Infantile Spasms Therapeutics Market Analysis and Forecast, by Country
-
9.3.1 China Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.2 Japan Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.3 Australia and New Zealand Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.4 India Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.5 ASEAN Countries Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
9.3.6 South Korea Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 10 Latin America, Middle East and Africa Infantile Spasms Therapeutics Market Analysis
-
10.1 Latin America, Middle East and Africa Infantile Spasms Therapeutics Market, by Type
-
10.2 Latin America, Middle East and Africa Infantile Spasms Therapeutics Market, by Application
-
10.3 Latin America, Middle East and Africa Infantile Spasms Therapeutics Market Analysis and Forecast, by Country
-
10.3.1 GCC Countries Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.2 Brazil Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.3 Nigeria Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.4 South Africa Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
-
10.3.5 Argentina Infantile Spasms Therapeutics Sales Volume, Sales Value and Growth Rate (2017-2028)
Chapter 11 Global and China Infantile Spasms Therapeutics Company Profiles
-
11.1 Orphelia Pharma
-
11.1.1 Orphelia Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.1.2 Orphelia Pharma Infantile Spasms Therapeutics Product Profiles, Application and Specification
-
11.1.3 Orphelia Pharma Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.2 Retrophin
-
11.2.1 Retrophin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.2.2 Retrophin Infantile Spasms Therapeutics Product Profiles, Application and Specification
-
11.2.3 Retrophin Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.3 Anavex Life Sciences
-
11.3.1 Anavex Life Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.3.2 Anavex Life Sciences Infantile Spasms Therapeutics Product Profiles, Application and Specification
-
11.3.3 Anavex Life Sciences Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.4 Valerion Therapeutics
-
11.4.1 Valerion Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.4.2 Valerion Therapeutics Infantile Spasms Therapeutics Product Profiles, Application and Specification
-
11.4.3 Valerion Therapeutics Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.5 H Lundbeck
-
11.5.1 H Lundbeck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.5.2 H Lundbeck Infantile Spasms Therapeutics Product Profiles, Application and Specification
-
11.5.3 H Lundbeck Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.6 Catalyst Pharmaceuticals
-
11.6.1 Catalyst Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.6.2 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product Profiles, Application and Specification
-
11.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.7 Insys Therapeutics
-
11.7.1 Insys Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.7.2 Insys Therapeutics Infantile Spasms Therapeutics Product Profiles, Application and Specification
-
11.7.3 Insys Therapeutics Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.8 Mallinckrodt
-
11.8.1 Mallinckrodt Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.8.2 Mallinckrodt Infantile Spasms Therapeutics Product Profiles, Application and Specification
-
11.8.3 Mallinckrodt Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
11.9 GW Pharmaceuticals
-
11.9.1 GW Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
11.9.2 GW Pharmaceuticals Infantile Spasms Therapeutics Product Profiles, Application and Specification
-
11.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
Chapter 12 Infantile Spasms Therapeutics Industry Investment Prospect and Risk Assessment
-
12.1 Infantile Spasms Therapeutics Industry Investment Prospect Assessment
-
12.1.1 Investment Opportunities in Segmented Markets
-
12.1.2 Investment Opportunities in Regional Markets
-
12.1.3 Investment Opportunities in Subdivided Industries
-
12.2 Infantile Spasms Therapeutics Industry Investment Risk Assessment
-
12.2.1 Competitive Risk Analysis
-
12.2.2 Technology Risk Analysis
-
12.2.3 Policies and Enterprise System Risk Analysis
List of Tables and Figures
-
Figure Global Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure China Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Global Infantile Spasms Therapeutics Production Value and Growth Rate (2017-2028)
-
Figure China Infantile Spasms Therapeutics Production Value and Growth Rate (2017-2028)
-
Figure Global Infantile Spasms Therapeutics Market Size and Growth Rate of Oral (2017-2028)
-
Figure Global Infantile Spasms Therapeutics Market Size and Growth Rate of Injection (2017-2028)
-
Figure Global Infantile Spasms Therapeutics Market Size and Growth Rate of Hospital (2017-2028)
-
Figure Global Infantile Spasms Therapeutics Market Size and Growth Rate of Clinic (2017-2028)
-
Figure North America Infantile Spasms Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Europe Infantile Spasms Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure APAC Infantile Spasms Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Latin America, Middle East and Africa Infantile Spasms Therapeutics Consumption Market Size and Growth Rate (2017-2028)
-
Figure Global Infantile Spasms Therapeutics Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)
-
Figure China Infantile Spasms Therapeutics Sales Volume, Price, Sales Value (2017-2028)
-
Figure Porter's Five Forces Model Analysis
-
Figure Industry PEST Analysis
-
Table Global and China Infantile Spasms Therapeutics Sales Volume, by Manufacturer (2021&2022)
-
Table Global and China Infantile Spasms Therapeutics Sales Value, by Manufacturer (2021&2022)
-
Table Global and China Infantile Spasms Therapeutics Market Share, by Manufacturer (2021&2022)
-
Figure Global and China Infantile Spasms Therapeutics Market Share, by Manufacturer in 2021
-
Figure Global and China Infantile Spasms Therapeutics Market Share, by Manufacturer in 2022
-
Table Global Infantile Spasms Therapeutics Sales Volume, by Type (2017-2028)
-
Table Global Infantile Spasms Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Global Infantile Spasms Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Global Infantile Spasms Therapeutics Sales Value, by Type (2017-2028)
-
Table Global Infantile Spasms Therapeutics Sales Value Share, by Type (2017-2028)
-
Figure Global Infantile Spasms Therapeutics Price Trend, by Type (2017-2028)
-
Table China Infantile Spasms Therapeutics Sales Volume, by Type (2017-2028)
-
Table China Infantile Spasms Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure China Infantile Spasms Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table China Infantile Spasms Therapeutics Sales Value, by Type (2017-2028)
-
Table China Infantile Spasms Therapeutics Sales Value Share, by Type (2017-2028)
-
Figure China Infantile Spasms Therapeutics Price Trend, by Type (2017-2028)
-
Table Global Infantile Spasms Therapeutics Sales Volume, by Application (2017-2028)
-
Table Global Infantile Spasms Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Global Infantile Spasms Therapeutics Sales Volume Share, by Application (2017-2028)
-
Table Global Infantile Spasms Therapeutics Sales Value, by Application (2017-2028)
-
Table Global Infantile Spasms Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure Global Infantile Spasms Therapeutics Sales Value Share, by Application (2017-2028)
-
Table China Infantile Spasms Therapeutics Sales Volume, by Application (2017-2028)
-
Table China Infantile Spasms Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure China Infantile Spasms Therapeutics Sales Volume Share, by Application (2017-2028)
-
Table China Infantile Spasms Therapeutics Sales Value, by Application (2017-2028)
-
Table China Infantile Spasms Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure China Infantile Spasms Therapeutics Sales Value Share, by Application (2017-2028)
-
Figure China Infantile Spasms Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure North America Infantile Spasms Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure Europe Infantile Spasms Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure APAC Infantile Spasms Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Figure Latin America, Middle East and Africa Infantile Spasms Therapeutics Production, Import, Consumption and Export (2017-2022)
-
Table North America Infantile Spasms Therapeutics Sales Volume, by Type (2017-2028)
-
Table North America Infantile Spasms Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure North America Infantile Spasms Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table North America Infantile Spasms Therapeutics Sales Volume, by Application (2017-2028)
-
Table North America Infantile Spasms Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure North America Infantile Spasms Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure United States Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure United States Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Canada Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Canada Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Mexico Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Mexico Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Europe Infantile Spasms Therapeutics Sales Volume, by Type (2017-2028)
-
Table Europe Infantile Spasms Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Europe Infantile Spasms Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Europe Infantile Spasms Therapeutics Sales Volume, by Application (2017-2028)
-
Table Europe Infantile Spasms Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Europe Infantile Spasms Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Germany Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Germany Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure UK Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure UK Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure France Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure France Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Italy Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Italy Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Nordic Countries Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Nordic Countries Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Spain Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Spain Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Belgium Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Belgium Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Poland Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Poland Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Russia Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Russia Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Turkey Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Turkey Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table APAC Infantile Spasms Therapeutics Sales Volume, by Type (2017-2028)
-
Table APAC Infantile Spasms Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure APAC Infantile Spasms Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table APAC Infantile Spasms Therapeutics Sales Volume, by Application (2017-2028)
-
Table APAC Infantile Spasms Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure APAC Infantile Spasms Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure China Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure China Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Japan Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Japan Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Australia and New Zealand Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure India Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure India Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure ASEAN Countries Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure ASEAN Countries Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure South Korea Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure South Korea Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Latin America, Middle East and Africa Infantile Spasms Therapeutics Sales Volume, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Infantile Spasms Therapeutics Sales Volume Share, by Type (2017-2028)
-
Figure Latin America, Middle East and Africa Infantile Spasms Therapeutics Sales Volume Share, by Type (2017-2028)
-
Table Latin America, Middle East and Africa Infantile Spasms Therapeutics Sales Volume, by Application (2017-2028)
-
Table Latin America, Middle East and Africa Infantile Spasms Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure Latin America, Middle East and Africa Infantile Spasms Therapeutics Sales Volume Share, by Application (2017-2028)
-
Figure GCC Countries Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure GCC Countries Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Brazil Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Brazil Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Nigeria Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Nigeria Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure South Africa Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure South Africa Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Figure Argentina Infantile Spasms Therapeutics Sales Volume and Growth Rate (2017-2028)
-
Figure Argentina Infantile Spasms Therapeutics Sales Value and Growth Rate (2017-2028)
-
Table Orphelia Pharma Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Orphelia Pharma Product Profiles, Application and Specification
-
Table Orphelia Pharma Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Retrophin Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Retrophin Product Profiles, Application and Specification
-
Table Retrophin Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Anavex Life Sciences Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Anavex Life Sciences Product Profiles, Application and Specification
-
Table Anavex Life Sciences Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Valerion Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Valerion Therapeutics Product Profiles, Application and Specification
-
Table Valerion Therapeutics Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table H Lundbeck Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table H Lundbeck Product Profiles, Application and Specification
-
Table H Lundbeck Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Catalyst Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Catalyst Pharmaceuticals Product Profiles, Application and Specification
-
Table Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Insys Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Insys Therapeutics Product Profiles, Application and Specification
-
Table Insys Therapeutics Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table Mallinckrodt Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table Mallinckrodt Product Profiles, Application and Specification
-
Table Mallinckrodt Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
Table GW Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position
-
Table GW Pharmaceuticals Product Profiles, Application and Specification
-
Table GW Pharmaceuticals Infantile Spasms Therapeutics Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)
-
